aluates Reports

$ 0.0

Automative

Global mRNA Therapy Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-34V13204

Global mRNA Therapy Market Research Report 2023

BUY CHAPTERS

Global mRNA Therapy Market Research Report 2025

Code: QYRE-Auto-34V13204

Report

June 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Moderna, Inc

BioNTech

Pfizer Inc

Arcturus Therapeutics Holdings Inc.

Astrazeneca plc

CureVac

Translate Bio

Regeneron Pharmaceuticals

Arcturus Therapeutics

Takeda Pharmaceutical Company

Novartis

Sanofi

mRNA Therapy Market Size

The global market for mRNA Therapy was valued at US$ 44900 million in the year 2024 and is projected to reach a revised size of US$ 105710 million by 2031, growing at a CAGR of 13.2% during the forecast period.

mRNA Therapy Market

By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for mRNA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Therapy.

The mRNA Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the mRNA Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of mRNA Therapy Market Report

Report Metric	Details
Report Name	mRNA Therapy Market
Accounted market size in year	US$ 44900 million
Forecasted market size in 2031	US$ 105710 million
CAGR	13.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Vaccine Drugs
Segment by Application	mRNA Targeted Delivery in vivo Genetically Modified T cells Transforming Nanoparticles to Develop Immunotherapy for Cancer Small Molecule Drugs Discovery
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca, CureVac, Translate Bio, Regeneron Pharmaceuticals, Arcturus Therapeutics, Takeda Pharmaceutical Company, Novartis, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is mRNA Therapy Market growing?

Ans: The mRNA Therapy Market witnessing a CAGR of 13.2% during the forecast period 2025-2031.

What is the mRNA Therapy Market size in 2031?

Ans: The mRNA Therapy Market size in 2031 will be US$ 105710 million.

Who are the main players in the mRNA Therapy Market report?

Ans: The main players in the mRNA Therapy Market are Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca, CureVac, Translate Bio, Regeneron Pharmaceuticals, Arcturus Therapeutics, Takeda Pharmaceutical Company, Novartis, Sanofi

What are the Application segmentation covered in the mRNA Therapy Market report?

Ans: The Applications covered in the mRNA Therapy Market report are mRNA Targeted Delivery in vivo, Genetically Modified T cells, Transforming Nanoparticles to Develop Immunotherapy for Cancer, Small Molecule Drugs Discovery

What are the Type segmentation covered in the mRNA Therapy Market report?

Ans: The Types covered in the mRNA Therapy Market report are Vaccine, Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Vaccine

1.2.3 Drugs

1.3 Market by Application

1.3.1 Global mRNA Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 mRNA Targeted Delivery in vivo

1.3.3 Genetically Modified T cells

1.3.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer

1.3.5 Small Molecule Drugs Discovery

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global mRNA Therapy Market Perspective (2020-2031)

2.2 Global mRNA Therapy Growth Trends by Region

2.2.1 Global mRNA Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 mRNA Therapy Historic Market Size by Region (2020-2025)

2.2.3 mRNA Therapy Forecasted Market Size by Region (2026-2031)

2.3 mRNA Therapy Market Dynamics

2.3.1 mRNA Therapy Industry Trends

2.3.2 mRNA Therapy Market Drivers

2.3.3 mRNA Therapy Market Challenges

2.3.4 mRNA Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top mRNA Therapy Players by Revenue

3.1.1 Global Top mRNA Therapy Players by Revenue (2020-2025)

3.1.2 Global mRNA Therapy Revenue Market Share by Players (2020-2025)

3.2 Global mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by mRNA Therapy Revenue

3.4 Global mRNA Therapy Market Concentration Ratio

3.4.1 Global mRNA Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Therapy Revenue in 2024

3.5 Global Key Players of mRNA Therapy Head office and Area Served

3.6 Global Key Players of mRNA Therapy, Product and Application

3.7 Global Key Players of mRNA Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Therapy Breakdown Data by Type

4.1 Global mRNA Therapy Historic Market Size by Type (2020-2025)

4.2 Global mRNA Therapy Forecasted Market Size by Type (2026-2031)

5 mRNA Therapy Breakdown Data by Application

5.1 Global mRNA Therapy Historic Market Size by Application (2020-2025)

5.2 Global mRNA Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America mRNA Therapy Market Size (2020-2031)

6.2 North America mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America mRNA Therapy Market Size by Country (2020-2025)

6.4 North America mRNA Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe mRNA Therapy Market Size (2020-2031)

7.2 Europe mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe mRNA Therapy Market Size by Country (2020-2025)

7.4 Europe mRNA Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific mRNA Therapy Market Size (2020-2031)

8.2 Asia-Pacific mRNA Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific mRNA Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific mRNA Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America mRNA Therapy Market Size (2020-2031)

9.2 Latin America mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America mRNA Therapy Market Size by Country (2020-2025)

9.4 Latin America mRNA Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa mRNA Therapy Market Size (2020-2031)

10.2 Middle East & Africa mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa mRNA Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa mRNA Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Moderna

11.1.1 Moderna Company Details

11.1.2 Moderna Business Overview

11.1.3 Moderna mRNA Therapy Introduction

11.1.4 Moderna Revenue in mRNA Therapy Business (2020-2025)

11.1.5 Moderna Recent Development

11.2 BioNTech

11.2.1 BioNTech Company Details

11.2.2 BioNTech Business Overview

11.2.3 BioNTech mRNA Therapy Introduction

11.2.4 BioNTech Revenue in mRNA Therapy Business (2020-2025)

11.2.5 BioNTech Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer mRNA Therapy Introduction

11.3.4 Pfizer Revenue in mRNA Therapy Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Arcturus Therapeutics Holdings Inc.

11.4.1 Arcturus Therapeutics Holdings Inc. Company Details

11.4.2 Arcturus Therapeutics Holdings Inc. Business Overview

11.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Introduction

11.4.4 Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2020-2025)

11.4.5 Arcturus Therapeutics Holdings Inc. Recent Development

11.5 Astrazeneca

11.5.1 Astrazeneca Company Details

11.5.2 Astrazeneca Business Overview

11.5.3 Astrazeneca mRNA Therapy Introduction

11.5.4 Astrazeneca Revenue in mRNA Therapy Business (2020-2025)

11.5.5 Astrazeneca Recent Development

11.6 CureVac

11.6.1 CureVac Company Details

11.6.2 CureVac Business Overview

11.6.3 CureVac mRNA Therapy Introduction

11.6.4 CureVac Revenue in mRNA Therapy Business (2020-2025)

11.6.5 CureVac Recent Development

11.7 Translate Bio

11.7.1 Translate Bio Company Details

11.7.2 Translate Bio Business Overview

11.7.3 Translate Bio mRNA Therapy Introduction

11.7.4 Translate Bio Revenue in mRNA Therapy Business (2020-2025)

11.7.5 Translate Bio Recent Development

11.8 Regeneron Pharmaceuticals

11.8.1 Regeneron Pharmaceuticals Company Details

11.8.2 Regeneron Pharmaceuticals Business Overview

11.8.3 Regeneron Pharmaceuticals mRNA Therapy Introduction

11.8.4 Regeneron Pharmaceuticals Revenue in mRNA Therapy Business (2020-2025)

11.8.5 Regeneron Pharmaceuticals Recent Development

11.9 Arcturus Therapeutics

11.9.1 Arcturus Therapeutics Company Details

11.9.2 Arcturus Therapeutics Business Overview

11.9.3 Arcturus Therapeutics mRNA Therapy Introduction

11.9.4 Arcturus Therapeutics Revenue in mRNA Therapy Business (2020-2025)

11.9.5 Arcturus Therapeutics Recent Development

11.10 Takeda Pharmaceutical Company

11.10.1 Takeda Pharmaceutical Company Company Details

11.10.2 Takeda Pharmaceutical Company Business Overview

11.10.3 Takeda Pharmaceutical Company mRNA Therapy Introduction

11.10.4 Takeda Pharmaceutical Company Revenue in mRNA Therapy Business (2020-2025)

11.10.5 Takeda Pharmaceutical Company Recent Development

11.11 Novartis

11.11.1 Novartis Company Details

11.11.2 Novartis Business Overview

11.11.3 Novartis mRNA Therapy Introduction

11.11.4 Novartis Revenue in mRNA Therapy Business (2020-2025)

11.11.5 Novartis Recent Development

11.12 Sanofi

11.12.1 Sanofi Company Details

11.12.2 Sanofi Business Overview

11.12.3 Sanofi mRNA Therapy Introduction

11.12.4 Sanofi Revenue in mRNA Therapy Business (2020-2025)

11.12.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Moderna, Inc

BioNTech

Pfizer Inc

Arcturus Therapeutics Holdings Inc.

Astrazeneca plc

CureVac

Translate Bio

Regeneron Pharmaceuticals

Arcturus Therapeutics

Takeda Pharmaceutical Company

Novartis

Sanofi

List of Tables

Table 1. Global mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Vaccine

Table 3. Key Players of Drugs

Table 4. Global mRNA Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global mRNA Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global mRNA Therapy Market Share by Region (2020-2025)

Table 8. Global mRNA Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global mRNA Therapy Market Share by Region (2026-2031)

Table 10. mRNA Therapy Market Trends

Table 11. mRNA Therapy Market Drivers

Table 12. mRNA Therapy Market Challenges

Table 13. mRNA Therapy Market Restraints

Table 14. Global mRNA Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global mRNA Therapy Market Share by Players (2020-2025)

Table 16. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2024)

Table 17. Ranking of Global Top mRNA Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by mRNA Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of mRNA Therapy, Headquarters and Area Served

Table 20. Global Key Players of mRNA Therapy, Product and Application

Table 21. Global Key Players of mRNA Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global mRNA Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global mRNA Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global mRNA Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global mRNA Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global mRNA Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global mRNA Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global mRNA Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global mRNA Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific mRNA Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific mRNA Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Moderna Company Details

Table 47. Moderna Business Overview

Table 48. Moderna mRNA Therapy Product

Table 49. Moderna Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 50. Moderna Recent Development

Table 51. BioNTech Company Details

Table 52. BioNTech Business Overview

Table 53. BioNTech mRNA Therapy Product

Table 54. BioNTech Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 55. BioNTech Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer mRNA Therapy Product

Table 59. Pfizer Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. Arcturus Therapeutics Holdings Inc. Company Details

Table 62. Arcturus Therapeutics Holdings Inc. Business Overview

Table 63. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product

Table 64. Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 65. Arcturus Therapeutics Holdings Inc. Recent Development

Table 66. Astrazeneca Company Details

Table 67. Astrazeneca Business Overview

Table 68. Astrazeneca mRNA Therapy Product

Table 69. Astrazeneca Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 70. Astrazeneca Recent Development

Table 71. CureVac Company Details

Table 72. CureVac Business Overview

Table 73. CureVac mRNA Therapy Product

Table 74. CureVac Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 75. CureVac Recent Development

Table 76. Translate Bio Company Details

Table 77. Translate Bio Business Overview

Table 78. Translate Bio mRNA Therapy Product

Table 79. Translate Bio Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 80. Translate Bio Recent Development

Table 81. Regeneron Pharmaceuticals Company Details

Table 82. Regeneron Pharmaceuticals Business Overview

Table 83. Regeneron Pharmaceuticals mRNA Therapy Product

Table 84. Regeneron Pharmaceuticals Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 85. Regeneron Pharmaceuticals Recent Development

Table 86. Arcturus Therapeutics Company Details

Table 87. Arcturus Therapeutics Business Overview

Table 88. Arcturus Therapeutics mRNA Therapy Product

Table 89. Arcturus Therapeutics Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 90. Arcturus Therapeutics Recent Development

Table 91. Takeda Pharmaceutical Company Company Details

Table 92. Takeda Pharmaceutical Company Business Overview

Table 93. Takeda Pharmaceutical Company mRNA Therapy Product

Table 94. Takeda Pharmaceutical Company Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 95. Takeda Pharmaceutical Company Recent Development

Table 96. Novartis Company Details

Table 97. Novartis Business Overview

Table 98. Novartis mRNA Therapy Product

Table 99. Novartis Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 100. Novartis Recent Development

Table 101. Sanofi Company Details

Table 102. Sanofi Business Overview

Table 103. Sanofi mRNA Therapy Product

Table 104. Sanofi Revenue in mRNA Therapy Business (2020-2025) & (US$ Million)

Table 105. Sanofi Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. mRNA Therapy Picture

Figure 2. Global mRNA Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global mRNA Therapy Market Share by Type: 2024 VS 2031

Figure 4. Vaccine Features

Figure 5. Drugs Features

Figure 6. Global mRNA Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global mRNA Therapy Market Share by Application: 2024 VS 2031

Figure 8. mRNA Targeted Delivery in vivo Case Studies

Figure 9. Genetically Modified T cells Case Studies

Figure 10. Transforming Nanoparticles to Develop Immunotherapy for Cancer Case Studies

Figure 11. Small Molecule Drugs Discovery Case Studies

Figure 12. mRNA Therapy Report Years Considered

Figure 13. Global mRNA Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global mRNA Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global mRNA Therapy Market Share by Region: 2024 VS 2031

Figure 16. Global mRNA Therapy Market Share by Players in 2024

Figure 17. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by mRNA Therapy Revenue in 2024

Figure 19. North America mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America mRNA Therapy Market Share by Country (2020-2031)

Figure 21. United States mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe mRNA Therapy Market Share by Country (2020-2031)

Figure 25. Germany mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific mRNA Therapy Market Share by Region (2020-2031)

Figure 33. China mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America mRNA Therapy Market Share by Country (2020-2031)

Figure 41. Mexico mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa mRNA Therapy Market Share by Country (2020-2031)

Figure 45. Turkey mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Moderna Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 49. BioNTech Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 51. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 52. Astrazeneca Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 53. CureVac Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 54. Translate Bio Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 55. Regeneron Pharmaceuticals Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 56. Arcturus Therapeutics Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 57. Takeda Pharmaceutical Company Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 58. Novartis Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 59. Sanofi Revenue Growth Rate in mRNA Therapy Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Synthesis Manufacturing Market Research Report 2024

Global mRNA Development and Manufacturing Services Market Research Report 2025

Global mRNA Vaccines and mRNA Drugs Market Research Report 2024

Global Gene Therapies for Cancer Treatment Market Research Report 2024

Global RNA Vaccines Market Insights Forecast to 2030

Global mRNA Vaccine Raw Materials Market Research Report 2024

Global RNA Therapeutics Market Research Report 2024

Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic Protein Drug Market Research Report 2024

Global Veterinary mRNA Vaccines Market Research Report 2025

Global mRNA Vaccine Drugs Development Services Market Research Report 2024

Global Livestock mRNA Vaccines Market Research Report 2025

mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Therapeutic Protein Market Research Report 2025

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18B20127

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36H20013

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7C20305

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13N20234

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions